丰原药业(000153.SZ)：上半年净利润7627.85万元 同比下降23.88%

Core Insights - Fengyuan Pharmaceutical (000153.SZ) reported a revenue of 2.027 billion yuan for the first half of 2025, representing a year-on-year decline of 12.16% [1] - The net profit attributable to shareholders was 76.2785 million yuan, down 23.88% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 60.5262 million yuan, a decrease of 29.32% compared to the previous year [1] - The basic earnings per share stood at 0.1641 yuan [1]